Fulvio Reggiori (1970) studied Biochemistry at the University of Fribourg, Switzerland, and in 1997, he obtained his PhD in Biochemistry from the same Institution. Here, in the laboratory of Prof. Andreas Conzelmann, he has worked on the remodeling of the lipid moiety of GPI-anchored proteins and on sphingolipid biosynthesis in yeast Saccharomyces cerevisiae. 

After staying one additional year in the same laboratory as a postdoctoral fellow, he moved to the MRC Laboratory of Molecular Biology in Cambridge, United Kingdom, in 1998. There, in the laboratory of Dr. Hugh Pelham, he investigated the signals targeting integral membrane proteins into the internal vesicles of multivesicular bodies.

In 2001, he joined the laboratory of Prof. Daniel Klionsky at the Life Sciences Institute of the University of Michigan in Ann Arbor (USA). There, he started working on different aspects of the molecular mechanism of autophagy in yeast.

In 2005, Fulvio Reggiori was appointed as a tenured Assistant Professor at the Department of Cell Biology of the University Medical Center Utrecht, where he started his independent research career working on the molecular mechanism of autophagy. The laboratory interests also extended to pathogens that subvert autophagy to invade host cells. In 2011, he became an Associate professor at the same Institution.

In 2022, Fulvio Reggiori became Professor at the Department of Biosciences of the University Medical Center Groningen, where he continued his investigations on the molecular mechanism of autophagy in yeast and on the interaction between pathogens and the ATG proteins.

Since 2022, he is a Professor at the Department of Biomedicine of Aarhus University, Denmark, where he is working on the same topics and has also started to explore how autophagy prevents neurodegeneration.